Fingerprint
Dive into the research topics of 'A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosis
Srdan Verstovsek, Ronald Hoffman, John Mascarenhas, Jean Charles Soria, Ratislav Bahleda, Patricia McCoon, Weifeng Tang, Jorge Cortes, Hagop Kantarjian, Vincent Ribrag
Research output: Contribution to journal › Article › peer-review
28
Scopus
citations